iBio Reports Fiscal Second Quarter 2022 Financial Results
BRYAN, Texas, Feb. 14, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and...
United States University Of Texas Southwestern Medical Center Tom Isett Stephen Kilmer Fastpharming Contract Development Texasam University
Source: globenewswire.com